Skeletal muscle has great plasticity. An increase in protein degradation can cause muscle atrophy. Atrogin-1 and muscle ring finger-1 (MuRF1) are dramatically upregulated in various muscle atrophy. Inhibition of Atrogin-1 and MuRF1 protects against muscle atrophy. MiR-29 plays an important regulatory role in skeletal muscle development. However, the function of miR-29 in skeletal muscle protein metabolism is not clear. To investigate the function of miR-29, we generated miR-29 knockout mice and the miR-29ab1 cluster overexpression mice. The disruption of miR-29 led to severe atrophy of skeletal muscle during puberty, and the muscle-specific overexpression of the miR-29ab1 cluster protected against denervation-induced and fasting-induced muscle atrophy. Furthermore, the overexpression of miR-29a, b mimics in myotubes resisted the muscle atrophy. MuRF1 was the direct target gene of miR-29a, b. These results demonstrate that miR-29ab1 cluster plays a critical role in the maintenance of skeletal muscle. MiR-29ab1 cluster is the excellent inhibitor of MuRF1, ultimately indicating that miR-29ab1 cluster is good therapeutic molecule candidate for adulthood.
Get full access to this article
View all access options for this article.
References
1.
BaehrL.M., FurlowJ.D., and BodineS.C. (2011). Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. The Journal of physiology, 589, 4759–4776.
2.
BodineS.C., and BaehrL.M. (2014). Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am J Physiol Endocrinol Metab, 307, E469–E484.
3.
BodineS.C., LatresE., BaumhueterS., LaiV.K., NunezL., ClarkeB.A., et al. (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science, 294, 1704–1708.
4.
BonaldoP., and SandriM. (2013). Cellular and molecular mechanisms of muscle atrophy. Dis Models Mech, 6, 25–39.
5.
ChenM., LiuC., WangM., WangH., ZhangK., ZhengY., et al. (2017). Clenbuterol induces cell cycle arrest in C2C12 myoblasts by delaying p27 degradation through beta-arrestin 2 signaling. Int J Biol Sci, 13, 1341–1350.
6.
ClarkeB.A., DrujanD., WillisM.S., MurphyL.O., CorpinaR.A., BurovaE., et al. (2007). The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab, 6, 376–385.
7.
CohenS., BraultJ.J., GygiS.P., GlassD.J., ValenzuelaD.M., GartnerC., et al. (2009). During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185, 1083–1095 (Research Support, N.I.H., Extramural Research, Support, Non-U.S. Gov't).
8.
CushingL., CostineanS., XuW., JiangZ., MaddenL., KuangP., et al. (2015). Disruption of miR-29 leads to aberrant differentiation of smooth muscle cells selectively associated with distal lung vasculature. PLoS Genet 11,e1005238.
9.
CushingL., KuangP.P., QianJ., ShaoF., WuJ., LittleF., et al. (2011). miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol, 45, 287–294.
10.
DayC.S., BuranapanitkitB., RianoF.A., TomainoM.M., SomogyiG., SotereanosD.G., et al. (2002). Insulin growth factor-1 decreases muscle atrophy following denervation. Microsurgery, 22, 144–151.
11.
DooleyJ., Garcia-PerezJ.E., SreenivasanJ., SchlennerS.M., VangoitsenhovenR., PapadopoulouA.S., et al. (2016). The microRNA-29 family dictates the balance between homeostatic and pathological glucose handling in diabetes and obesity. Diabetes, 65, 53–61.
12.
GalimovA., MerryT.L., LucaE., RushingE.J., MizbaniA., TurcekovaK., et al. (2016). MicroRNA-29a in adult muscle stem cells controls skeletal muscle regeneration during injury and exercise downstream of fibroblast growth factor-2. Stem cells, 34, 768–780.
13.
GeM., LiuC., LiL., LanM., YuY., GuL., et al. (2019). miR-29a/b1 inhibits hair follicle stem cell lineage progression by spatiotemporally suppressing WNT and BMP signaling. Cell Rep, 29, 2489–2504.e2484.
HuZ., KleinJ.D., MitchW.E., ZhangL., MartinezI., and WangX.H. (2014). MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways. Aging, 6, 160–175 (Research Support, N.I.H., Extramural).
16.
LatresE., AminiA.R., AminiA.A., GriffithsJ., MartinF.J., WeiY., et al. (2005). Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem, 280, 2737–2744.
17.
LeckerS.H., JagoeR.T., GilbertA., GomesM., BaracosV., BaileyJ., et al. (2004). Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J, 18, 39–51.
18.
LexellJ., TaylorC.C., and SjostromM. (1988). What is the cause of the ageing atrophy?. Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci, 84, 275–294.
19.
LiJ., ChanM.C., YuY., BeiY., ChenP., ZhouQ., et al. (2017). miR-29b contributes to multiple types of muscle atrophy. Nat Commun 8,15201.
20.
LiuC., LiL., GeM., GuL., WangM., ZhangK., et al. (2019). Overexpression of miR-29 leads to myopathy that resemble pathology of ullrich congenital muscular dystrophy. Cells 8,459.
21.
LiuC., WangM., ChenM., ZhangK., GuL., LiQ., et al. (2017). miR-18a induces myotubes atrophy by down-regulating IgfI. Int J Biochem Cell Biol, 90, 145–154.
22.
LiuY., LiY., ZhangD., LiuJ., GouK., and CuiS. (2015). Mitogen-activated protein kinase 8 (MAP3K8) mediates the signaling pathway of estradiol stimulating progesterone production through G protein-coupled receptor 30 (GPR30) in mouse corpus luteum. Mol Endocrinol, 29, 703–715.
23.
MassartJ., SjogrenR.J.O., LundellL.S., MudryJ.M., FranckN., O'GormanD.J., et al. (2017). Altered miR-29 expression in type 2 diabetes influences glucose and lipid metabolism in skeletal muscle. Diabetes, 66, 1807–1818.
24.
MilanG., RomanelloV., PescatoreF., ArmaniA., PaikJ.H., FrassonL., et al. (2015). Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy. Nat Commun 6,6670.
25.
MoraesL.N., FernandezG.J., Vechetti-JuniorI.J., FreireP.P., SouzaR.W.A., VillacisR.A.R., et al. (2017). Integration of miRNA and mRNA expression profiles reveals microRNA-regulated networks during muscle wasting in cardiac cachexia. Sci Rep 7,6998.
26.
RelaixF., and ZammitP.S. (2012). Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development, 139, 2845–2856.
SilvaW.J., GracaF.A., CruzA., SilvestreJ.G., LabeitS., MiyabaraE.H., et al. (2019). miR-29c improves skeletal muscle mass and function throughout myocyte proliferation and differentiation and by repressing atrophy-related genes. Acta Physiol (Oxf) 226,e13278.
29.
UrlingerS., BaronU., ThellmannM., HasanM.T., BujardH., and HillenW. (2000). Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A, 97, 7963–7968.
30.
WangH., GarzonR., SunH., LadnerK.J., SinghR., DahlmanJ., et al. (2008). NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer cell, 14, 369–381.
31.
WangH., WangB., ZhangA., HassounahF., SeowY., WoodM., et al. (2019). Exosome-mediated miR-29 transfer reduces muscle atrophy and kidney fibrosis in mice. Mol Ther, 27, 571–583.
32.
WangL., ZhouL., JiangP., LuL., ChenX., LanH., et al. (2012). Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther, 20, 1222–1233.
33.
WangY., and PessinJ.E. (2013). Mechanisms for fiber-type specificity of skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care, 16, 243–250.
34.
WeiW., HeH.B., ZhangW.Y., ZhangH.X., BaiJ.B., LiuH.Z., et al. (2013). miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis 4,e668.
35.
WinbanksC.E., WangB., BeyerC., KohP., WhiteL., KantharidisP., et al. (2011). TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem, 286, 13805–13814.
36.
ZhangN., LinJ.K., ChenJ., LiuX.F., LiuJ.L., LuoH.S., et al. (2013). MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8. J Biol Chem, 288, 10361–10373.
37.
ZhouL., WangL., LuL., JiangP., SunH., and WangH. (2012). Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts. PLoS One 7,e33766.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
